Instructions for Credit - There is no fee for this activity. To receive credit for this CME/CE activity, review the accreditation and disclosure information, view the presentation in its entirety, successfully complete the post-activity assessment and evaluation. If you do not achieve a minimum score of 70% on the post-activity assessment, you will be allowed to take it again. This course is accredited for up to 1.0 continuing education credit. Please retain a copy of the certificate for your records.



Target Audience:
Pediatricians, family physicians, oncologists, pediatric hematologist-oncologists, physician assistants, nurse practitioners, nurses, and oncology social workers.

Course content level for social workers: intermediate and advanced

Learning Objectives:
At the conclusion of this program, participants will be able to:

  • Describe an overview of long-term and late effects of treatment for childhood blood cancers
  • Explain the importance of following a care plan, consultation in a survivorship program and communication between the treating pediatrician/family physician and family
  • Address survivorship guidelines, including screening and management strategies
  • Identify strategies and resources to support survivors, including as they continue their education

Speakers:
Tara O. Henderson, MD, MPH, FASCO
Professor of Pediatrics
Director
, Childhood, Adolescent and Young Adult Survivorship Center
Director, Cancer Survivorship and Co-Leader, Cancer Prevention and
Control Program
Comprehensive Cancer Center
The University of Chicago
Chicago, IL

Danielle Novetsky Friedman, MD, MS
Assistant Member
Pediatric Long-Term Follow-Up Program
Memorial Sloan Kettering Cancer Center
New York, NY

CME/CE Information:
Physician Credit Designation
The Survivorship Care for Childhood and Adolescent Blood Cancer program is approved for 1.0 prescribed credit hour by the American Academy of Family Physicians (AAFP). Please complete the evaluation to obtain CME credit.

Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.

Social Work Credit Designation
Survivorship Care for Childhood and Adolescent Blood Cancer, Course #3221, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by The Leukemia & Lymphoma Society as an individual course. Individual courses, not providers, are approved at the course level. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. ACE course approval period: 01/20/2021 - 01/20/2023. Social workers completing this course receive 1 Clinical continuing education credit.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for this program. Social workers will receive 1 CE clinical contact hour for this activity.

All continuing education credits are provided free of charge.

Disclosure of Conflicts of Interest:
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker's bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Clinical Directors Network, Inc. and The Leukemia & Lymphoma Society for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Providers:
The associates of Clinical Directors Network, Inc. and The Leukemia & Lymphoma Society, the accredited providers for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME/CE activity during the past 12 months.

Faculty Disclosures:
Dr. Henderson has received research grants from Seattle Genetics
Dr. Friedman has no affiliations to disclose

Disclaimer:
The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

System Requirements:
An active internet connection with Web browser is required to view this activity.

Estimated time to complete activity: 1.0 hour
Date of initial release: September 11, 2020
Valid for CME credit through: July 16, 2021
Valid for CE credit through: September 11, 2021